TradingMarkets winners & losers
St. Louis, Missouri-based biotech and
agricultural products giant Monsanto Co.
(
MON |
Quote |
Chart |
News |
PowerRating)
announced third quarter results, reporting earnings that rose six-fold from last
year on top line growth, boosted mainly by higher revenues from the U.S. seeds
and traits business (full
story).
German healthcare company
Bayer AG’s
(
BAY |
Quote |
Chart |
News |
PowerRating) stock rose 6.42% or $2.70 on Thursday after
announcing plans to sell the Diagnostics Division of Bayer HealthCare to Siemens
AG for EUR 4.2 billion (full
story).
Computer Sciences Corp.
(
CSC |
Quote |
Chart |
News |
PowerRating) ended talks of a potential sale, as it announced that its Board had
approved a $2 billion share buyback scheme (full
story).
Cephalon Inc.
(
CEPH |
Quote |
Chart |
News |
PowerRating)
announced that it received an approvable letter for FENTORA from the FDA.
Fentora is a fentanyl buccal tablet for the treatment of breakthrough pain in
opioid-tolerant patients with cancer (full
story).
Pharmaceuticals, Inc.
(
BRL |
Quote |
Chart |
News |
PowerRating)
on early Friday revealed that the company has increased its offer to purchase
Croatian generic drug manufacturer PLIVA to about $2.3 billion in cash (full
story).
Celgene Corp.
(
CELG |
Quote |
Chart |
News |
PowerRating)
received approval by the U.S. Food and Drug Administration or FDA of its
Supplemental New Drug Application for an additional indication for Revlimid in
combination with dexamethasone for treatment of multiple myeloma (full
story).
Copyright(c) 2006 RealTimeTraders.com, Inc. All Rights
Reserved